These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 16927942)
1. [Nonspecific ulcerative colitis and Crohn's disease--the main problem of modern coloproctology]. Zakharash MP Klin Khir; 2006 Jun; (6):40-4. PubMed ID: 16927942 [TBL] [Abstract][Full Text] [Related]
2. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
3. [Inflammatory diseases of the intestines]. Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P Rev Med Suisse; 2006 Jan; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody]. Asakura H Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969 [TBL] [Abstract][Full Text] [Related]
8. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation]. MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443 [No Abstract] [Full Text] [Related]
13. Medical treatment of inflammatory bowel disease: new therapies, new drugs. Sutherland LR CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889 [TBL] [Abstract][Full Text] [Related]
14. Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's disease. Zimmerman MJ; Jewell DP Aliment Pharmacol Ther; 1996; 10 Suppl 2():93-8; discussion 99. PubMed ID: 8899107 [TBL] [Abstract][Full Text] [Related]
15. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis. Hibi T; Iwao Y; Yajima T; Inoue N; Ueno Y; Takaishi H; Watanabe M; Ishii H J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872 [TBL] [Abstract][Full Text] [Related]
17. [Contemporary views on non-specific ulcerative colitis and conservative methods of its treatment ]. Bakulin IG; Stanke DA Voen Med Zh; 2008 Nov; 329(11):50-4. PubMed ID: 19186525 [No Abstract] [Full Text] [Related]
18. [New therapeutic data in inflammatory colitis]. Karsenti P Ann Gastroenterol Hepatol (Paris); 1996; 32(1):10. PubMed ID: 8669802 [No Abstract] [Full Text] [Related]
19. [Inflammatory bowel diseases (Crohn disease and ulcerative colitis). Possibilities and limitations of surgical therapy]. Ackermann C; Tondelli P Ther Umsch; 1991 Jul; 48(7):471-9. PubMed ID: 1926007 [TBL] [Abstract][Full Text] [Related]
20. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. Magro F; Portela F BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]